Paul Glossop
Paul Glossop
Sandexis
Verified email at sandexis.co.uk
Title
Cited by
Cited by
Year
Inhalation by design: novel ultra-long-acting β2-adrenoreceptor agonists for inhaled once-daily treatment of asthma and chronic obstructive pulmonary disease that utilize a …
PA Glossop, CAL Lane, DA Price, ME Bunnage, RA Lewthwaite, K James, ...
Journal of medicinal chemistry 53 (18), 6640-6652, 2010
692010
Stereoselective synthesis of pyrrolidines: catalytic oxidative cyclizations mediated by osmium
TJ Donohoe, GH Churchill, PA Glossop
Angewandte Chemie 118 (47), 8193-8196, 2006
502006
The discovery of long acting β< sub> 2</sub>-adrenoreceptor agonists
AD Brown, ME Bunnage, PA Glossop, K James, R Jones, CAL Lane, ...
Bioorganic & medicinal chemistry letters 17 (14), 4012-4015, 2007
492007
Inhibition of TRPM8 channels reduces pain in the cold pressor test in humans
WJ Winchester, K Gore, S Glatt, W Petit, JC Gardiner, K Conlon, ...
Journal of Pharmacology and Experimental Therapeutics 351 (2), 259-269, 2014
472014
Pyridine‐N‐Oxide as a Mild Reoxidant Which Transforms Osmium‐Catalyzed Oxidative Cyclization
TJ Donohoe, PJ Lindsay‐Scott, PA Glossop, IA Nash, JS Parker
Angewandte Chemie 120 (15), 2914-2917, 2008
392008
The discovery of adamantyl-derived, inhaled, long acting β< sub> 2</sub>-adrenoreceptor agonists
AD Brown, ME Bunnage, PA Glossop, K James, R Jones, CAL Lane, ...
Bioorganic & medicinal chemistry letters 18 (4), 1280-1283, 2008
362008
The discovery of indole-derived long acting β< sub> 2</sub>-adrenoceptor agonists for the treatment of asthma and COPD
AD Brown, ME Bunnage, PA Glossop, M Holbrook, RD Jones, CAL Lane, ...
Bioorganic & medicinal chemistry letters 17 (22), 6188-6191, 2007
282007
Inhalation by design: novel tertiary amine muscarinic m3 receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive …
PA Glossop, CAL Watson, DA Price, ME Bunnage, DS Middleton, A Wood, ...
Journal of medicinal chemistry 54 (19), 6888-6904, 2011
272011
Progress in the Development of Inhaled, Long-Acting b2-Adrenoceptor Agonists
PA Glossop, DA Price
Annual Reports in Medicinal Chemistry 41, 237, 2006
222006
Identification of Type‐II Inhibitors Using Kinase Structures
F Lovering, J McDonald, GA Whitlock, PA Glossop, C Phillips, A Bent, ...
Chemical Biology & Drug Design 80 (5), 657-664, 2012
182012
Studies on DMDO-mediated benzylidene acetal oxidation
DK Mycock, AE Sherlock, PA Glossop, CJ Hayes
Tetrahedron Letters 49 (45), 6390-6392, 2008
172008
COMPOUNDS HAVING BETA-AGONIST ACTIVITY
A BROWN, M BUNNAGE, K BUTCHER, P GLOSSOP, K JAMES, C LANE, ...
WO Patent 2,005,092,841, 2005
17*2005
Osmium‐Mediated Oxidative Cyclizations: A Study into the Range of Initiators That Facilitate Cyclization
TJ Donohoe, PJ Lindsay‐Scott, GH Churchill, MJ Connolly, S Butterworth, ...
Chemistry–An Asian Journal 4 (8), 1237-1247, 2009
162009
Development of a Scaleable Synthesis of a Geminal Dimethyl Tertiary Amine as an Inhaled Muscarinic Antagonist for the Treatment of COPD
BR Dillon, DF Roberts, DA Entwistle, PA Glossop, CJ Knight, DA Laity, ...
Organic Process Research & Development 16 (2), 195-203, 2012
152012
NICOTINAMIDE DERIVATIVES USEFUL AS PDE4 INHIBITORS
SP Bailey, CG Barber, PA Glossop, DS Middleton
EP Patent 1,651,609, 2006
152006
Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure–activity relationships of substituted (1< i> S</i>, 4< i> S</i>)-4-(3, 4-dichlorophenyl)-< i …
DS Middleton, M Andrews, P Glossop, G Gymer, A Jessiman, PS Johnson, ...
Bioorganic & medicinal chemistry letters 16 (5), 1434-1439, 2006
152006
NICOTINAMIDE DERIVATIVES USEFUL AS PDE4 INHIBITORS
S BAILEY, C BARBER, P GLOSSOP, D MIDDLETON
WO Patent 2,005,009,966, 2005
152005
Nicotinamide derivatives useful as PDE4 inhibitors
S Bailey, CG Barber, PA Glossop, DS Middleton
US Patent 7,141,586, 2006
142006
Design and synthesis of long acting inhaled corticosteroids for the treatment of asthma
DS Millan, SA Ballard, S Chunn, JA Dybowski, CK Fulton, PA Glossop, ...
Bioorganic & medicinal chemistry letters 21 (19), 5826-5830, 2011
132011
Designing rapid onset selective serotonin re-uptake inhibitors. Part 3: site-directed metabolism as a strategy to avoid active circulating metabolites: Structure–activity …
DS Middleton, M Andrews, P Glossop, G Gymer, D Hepworth, A Jessiman, ...
Bioorganic & medicinal chemistry letters 18 (19), 5303-5306, 2008
122008
The system can't perform the operation now. Try again later.
Articles 1–20